Preprocedural Troponin T Levels Predict the Improvement in the Left Ventricular Ejection Fraction After Catheter Ablation of Atrial Fibrillation/Flutter.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
07 04 2020
Historique:
entrez: 24 3 2020
pubmed: 24 3 2020
medline: 9 3 2021
Statut: ppublish

Résumé

Background Left ventricular (LV) systolic dysfunction is reversible in some patients once the arrhythmia is controlled. However, identifying this arrhythmia-induced cardiomyopathy among patients with LV systolic dysfunction is challenging. We explored the factors predicting the reversibility of the LV ejection fraction (LVEF) after catheter ablation of atrial fibrillation and/or atrial flutter in patients with LV systolic dysfunction. Methods and Results Forty patients with a reduced LVEF (LVEF <50%; 66.2±10.7 years; 32 men) who underwent atrial fibrillation/atrial flutter ablation were included. Transthoracic echocardiography was performed before and during the early (<4 days) and late phases (>3 months) after the ablation. Responders were defined as having a normalized LVEF (≥50%) during the late phase after the ablation. The LVEF improved from 39.8±8.8 to 50.9±10.9% at 1.2±0.6 days after the procedure, and to 56.2±12.2% at 9.6±8.0 months after the procedure (both for

Identifiants

pubmed: 32200728
doi: 10.1161/JAHA.119.015126
pmc: PMC7428643
doi:

Substances chimiques

Biomarkers 0
Troponin T 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e015126

Références

J Am Coll Cardiol. 2012 Nov 20;60(21):2194-204
pubmed: 23103045
J Am Coll Cardiol. 2013 Nov 19;62(21):1990-1997
pubmed: 23850917
Cardiol J. 2014;21(5):516-23
pubmed: 24293166
Eur Heart J. 2016 Aug;37(31):2478-87
pubmed: 26984861
J Am Coll Cardiol. 2017 Oct 17;70(16):1949-1961
pubmed: 28855115
J Am Coll Cardiol. 2019 May 14;73(18):2328-2344
pubmed: 31072578
J Arrhythm. 2017 Oct;33(5):369-409
pubmed: 29021841
J Atr Fibrillation. 2013 Jun 30;6(1):877
pubmed: 28496861
Circulation. 2001 Jan 23;103(3):369-74
pubmed: 11157687
Circulation. 2011 Jun 21;123(24):2811-8
pubmed: 21632491
J Am Coll Cardiol. 2013 May 7;61(18):1894-903
pubmed: 23500267
Eur Heart J. 2008 Sep;29(18):2252-8
pubmed: 18606612
J Am Heart Assoc. 2020 Apr 7;9(7):e015126
pubmed: 32200728
Heart Vessels. 2020 Feb;35(2):239-245
pubmed: 31346694
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):31-8
pubmed: 24382410
Circ J. 2013;77(7):1695-704
pubmed: 23535197
Cardiovasc Res. 2017 Dec 1;113(14):1708-1718
pubmed: 29016754
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Am Coll Cardiol. 2010 Sep 28;56(14):1071-8
pubmed: 20863950
Circulation. 2003 Aug 19;108(7):833-8
pubmed: 12912820
JAMA Cardiol. 2016 Aug 1;1(5):510-8
pubmed: 27434402
J Cardiovasc Electrophysiol. 2019 Sep;30(9):1475-1482
pubmed: 31192482
Int Heart J. 2015 May 13;56(3):309-13
pubmed: 25912901
J Cardiol. 2018 Sep;72(3):240-246
pubmed: 29609877
Circulation. 2016 Apr 26;133(17):1637-44
pubmed: 27029350
N Engl J Med. 2018 Feb 01;378(5):417-427
pubmed: 29385358

Auteurs

Daisetsu Aoyama (D)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Shinsuke Miyazaki (S)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Kanae Hasegawa (K)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Kenichi Kaseno (K)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Eri Ishikawa (E)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Moe Mukai (M)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Minoru Nodera (M)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Kosuke Miyahara (K)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Akira Matsui (A)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Yuichiro Shiomi (Y)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Naoto Tama (N)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Hiroyuki Ikeda (H)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Yoshitomo Fukuoka (Y)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Tetsuji Morishita (T)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Kentaro Ishida (K)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Hiroyasu Uzui (H)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Hiroshi Tada (H)

Department of Cardiovascular Medicine Faculty of Medical Sciences University of Fukui Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH